超180亿美元!多家巨头同时宣布大额收购,强生、礼来、GSK等

新康界
16 Jan

今日,强生(Johnson & Johnson)公司宣布斥资约146亿美元收购专注于开发中枢神经系统疾病疗法的Intra-Cellular Therapies公司。礼来(Eli Lilly and Company)宣布与Scorpion Therapeutics达成收购协议,潜在斥资25亿美元囊获选择性PI3Kα抑制剂。GSK则宣布将斥资11.5亿美元收购IDRx。下面我们来看看这些并购将加强三家...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10